Skip to main content
VCbacked
Log inGet Started

TNF Pharmaceuticals

Baltimore, United States

TNF Pharmaceuticals is researching groundbreaking treatments to address serious and debilitating autoimmune and inflammatory illnesses.

$7.0M raised
Sep 2025
Post-IPO Equity
BiotechnologyClinical TrialsPharmaceutical

Top Investors

PharmaCyte Biotech

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about TNF Pharmaceuticals

How much funding has TNF Pharmaceuticals raised?
TNF Pharmaceuticals has raised $7.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in September 2025.
Who are TNF Pharmaceuticals's investors?
TNF Pharmaceuticals's investors include PharmaCyte Biotech.
Where is TNF Pharmaceuticals headquartered?
TNF Pharmaceuticals is headquartered in Baltimore, United States.
What does TNF Pharmaceuticals do?
TNF Pharmaceuticals is researching groundbreaking treatments to address serious and debilitating autoimmune and inflammatory illnesses.
What stage is TNF Pharmaceuticals at?
TNF Pharmaceuticals is at the Post-IPO Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"TNF Pharmaceuticals — Funding & Investors." VCBacked, September 2, 2025, https://www.vcbacked.co/company/tnf-pharmaceuticals. Accessed July 4, 2026.
APA
VCBacked. (2025). TNF Pharmaceuticals — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/tnf-pharmaceuticals
Wikipedia (cite web)
{{cite web |title=TNF Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/tnf-pharmaceuticals |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Rapport Therapeutics
Boston$250.0M
Allterum Therapeutics
Houston$1.0M
AlpalifeBio
Woburn$9.8M
Renaissance BioScience
Vancouver$599K
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K